Dexcom | DXCM - PE价格收益



金融业
股票价格
USD
资产
USD 6.46B
现金及等价物
USD 1.11B
销售成本
USD 478.4M
流动资产
USD 4.09B
流动负债
USD 2.36B
债务
USD 1.24B
EBIT
USD 318.3M
EBITDA
USD 364.5M
员工
10.3K
EPS每股收益
USD 0.7
股本和储备
USD 2.62B
销售毛利
USD 750.3M
债务利息支出
USD 3.1M
利息收入
USD 19.5M
贷款资金
USD 1.3B
市值
USD 32.51B
净收入
USD 249.1M
营业费用
USD 990.1M
营业利润
USD 318.3M
普通股股本
USD 377.4M
PE价格收益
24.61
税前利润
USD 269.5M
销售收入
USD 1.31B
销售和管理费用
USD 358.7M
股票
USD 726.4M
贸易债权人
USD 2.08B
应收帐款人
USD 1.27B


Pe 更改 日
Abbott 23.85 1.08 2026-06
Align Technology 21.8 0.98 2026-06
AtriCure 129.01 94.86 2026-06
Baxter International 151.95 65.95 2026-06
Becton, Dickinson and Co. 16.04 9.65 2026-06
Boston Scientific 17.86 14.49 2026-06
Cooper Companies 23.27 16.99 2026-03
Dexcom 24.61 0.12 2026-06
Edwards Lifesciences 30.77 3.9 2026-06
Globus Medical 22.31 12.99 2026-06
Inogen 69.33 30.67 2021-09
Insulet 29.66 9.17 2026-06
Integra LifeSciences 10.28 5.21 2026-06
J&J 29.43 4.9 2026-06
Medtronic 19.66 3.1 2026-03
Merit Medical Systems 32.36 12.84 2026-03
Roche Holding 16.48 0.39 2026-06
Solventum Corp 43.68 145.42 2026-06
Stryker 27.46 2.98 2026-06
Tandem Diabetes Care 681.05 189.32 2022-03
Teleflex 89.77 40.52 2026-06
West Pharmaceutical Services 42.63 10.64 2026-06
Zimmer Biomet Holdings 17.33 8.14 2026-06